Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10000491 Process for producing diazabicyclooctane derivative and intermediate thereof

Patent 10000491 was granted and assigned to Meiji Seika Pharma on June, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Meiji Seika Pharma

Current Assignee

Meiji Seika Pharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10000491

Date of Patent

June 19, 2018

Patent Application Number

15023976

Date Filed

September 24, 2014

Patent Citations Received

‌

US Patent 12103928 Processes for preparing a diazabicyclooctane compound

‌

US Patent 11751775 Electrical device for monitoring, prevention, and treatment of implant infections

‌

US Patent 11414417 Crystalline forms of diazabicyclooctane derivative and production process thereof

‌

US Patent 11957690 Chromogenic beta-lactamase substrate

Patent Primary Examiner

‌

Noble Jarrell

Patent abstract

A process for producing a diazabicyclooctane derivative represented by Formula (IV) and intermediates thereof by carrying out the following steps:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10000491 Process for producing diazabicyclooctane derivative and intermediate thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API